Question 12

IV propranolol is considered a high-alert medication in acute care settings because it is an adrenergic antagonist.

Propranolol is classified as an adrenergic antagonist, which means it blocks the effects of adrenaline on the body. This classification is crucial in acute care settings due to the potential for significant adverse effects if not administered correctly.

A) adrenergic antagonist

This option is correct because propranolol's role as an adrenergic antagonist is vital in managing conditions such as hypertension and anxiety. Its high-alert status arises from the risks associated with its usage, including bradycardia and hypotension, especially in vulnerable patient populations.

B) chemotherapeutic agent

This option is incorrect as propranolol is not classified as a chemotherapeutic agent. Chemotherapeutic agents are specifically used to treat cancer, whereas propranolol is primarily used for cardiovascular conditions and anxiety management.

C) opioid

This option is incorrect because propranolol is not an opioid. Opioids are a class of drugs used primarily for pain relief, while propranolol serves a different therapeutic purpose as a beta-blocker affecting the cardiovascular system.

D) anticoagulant

This option is incorrect as propranolol does not function as an anticoagulant. Anticoagulants are medications that prevent blood clotting, whereas propranolol’s action is focused on blocking adrenergic receptors, which does not pertain to blood coagulation.

Conclusion

The classification of propranolol as an adrenergic antagonist underlines its significance as a high-alert medication due to the potential for serious side effects if mismanaged. Other options like chemotherapeutic agents, opioids, and anticoagulants do not accurately describe propranolol’s pharmacological profile, reinforcing why they are not correct in this context. Understanding this classification is essential for ensuring patient safety in acute care settings.